ArticleJournal of translational medicine2026
Integrative single-cell and spatial transcriptomic analysis reveals a lactate-driven crosstalk between NFATc4⁺ tumor cells and SPP1⁺ macrophages in glioblastoma.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundGlioblastoma (GBM) remains a lethal brain tumor with limited therapeutic options. Metabolic reprogramming, particularly lactate metabolism, plays a critical role in tumor progression and immune evasion.
methodsHere, we integrated single-cell RNA sequencing (scRNA-seq), spatial transcriptomics, and machine learning to investigate the heterogeneity of lactate metabolism in GBM.
resultsUsing scRNA-seq data (GSE138794), we classified neoplastic cells into high- and low-lactate subgroups and identified nuclear factor of activated T-cells cytoplasmic 4 (NFATc4) as a key transcription factor associated with elevated lactate metabolism. Pseudotime trajectory analysis revealed dynamic upregulation of NFATc4 during neoplastic cell differentiation, correlating with invasive phenotypes. Spatial transcriptomics (GSE194329) demonstrated colocalization of NFATc4⁺ tumor cells with SPP1⁺ macrophages, suggesting their microenvironmental crosstalk. A prognostic model constructed via 101 machine-learning algorithms (StepCox[forward] + RSF) achieved favorable performance across independent cohorts (TCGA, CGGA, GSE108474, GSE4412, and meta-cohort). Patients with different risk levels showed distinct immune infiltration, copy number alterations, and drug-sensitivity profiles. In vitro functional assays confirmed that NFATc4 knockdown in GBM cells suppressed tumor cell proliferation, migration, and cell cycle while promoting apoptosis. Besides, NFATc4 knockdown in GBM cells reduced SPP1 expression, migration, and M2-like polarization of co-cultured macrophages. Moreover, silencing SPP1 in macrophages attenuated the pro-tumorigenic effects on co-cultured GBM cells, validating the functional relevance of the NFATc4-SPP1 axis.
conclusionOur study reveals lactate metabolism-related NFATc4 as a promising therapeutic target in GBM, with implications for prognosis stratification and combination therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.